Removal or ablation of asymptomatic lung metastases should be reconsidered
BMJ
.
2023 Nov 9:383:e073042.
doi: 10.1136/bmj-2022-073042.
Authors
Fergus Macbeth
1
,
Lesley Fallowfield
2
,
Elizabeth Treasure
3
,
Irfan Ahmad
4
,
Yan Zheng
5
,
Tom Treasure
6
Affiliations
1
Centre for Trials Research, Cardiff University, Cardiff, UK.
2
Sussex Health Outcomes Research and Education in Cancer, University of Sussex, Sussex, UK.
3
Patient author, Oxford University Counselling Service, University of Oxford, Oxford, UK tom.treasure@gmail.com.
4
Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Centre, New Delhi, India.
5
Department of Thoracic Surgery, Affiliated Cancer Hospital of ZhengZhou University/Henan Cancer Hospital, People's Republic of China.
6
Clinical Operational Research Unit, University College London, London, UK tom.treasure@gmail.com.
PMID:
37945005
DOI:
10.1136/bmj-2022-073042
No abstract available